Chimerism Post-Engraftment Test sale cost 1330 AED
FISH - Opposite Sex BMT XX XY Test sale cost 1200 AED FISH - Opposite Sex BMT XX XY Test 1,500 د.إ Original price was: 1,500 د.إ.1,200 د.إCurrent price is: 1,200 د.إ.
Cytomegalovirus CMV Qualitative PCR Test sale cost 1000 AED Cytomegalovirus CMV Qualitative PCR Test 1,300 د.إ Original price was: 1,300 د.إ.1,000 د.إCurrent price is: 1,000 د.إ.
Sale!

Chimerism Post-Engraftment Test

Original price was: 1,480 د.إ.Current price is: 1,330 د.إ.

-10%

The “Chimerism Post-Engraftment Test” is a specialized medical examination conducted to evaluate the success of a bone marrow or stem cell transplant. This test is essential in the post-engraftment phase, a period following the transplant when the donor’s stem cells have begun to establish and produce new blood cells in the recipient’s body. By analyzing the genetic markers present in the blood or bone marrow, the test quantifies the proportion of donor and recipient cells, helping to assess whether the transplant is functioning as intended.

A key aspect of post-transplant care, chimerism testing allows healthcare providers to monitor the patient’s progress and detect potential complications early, such as graft-versus-host disease (GVHD) or graft failure. Adjustments in immunosuppressive therapy or other treatments may be made based on the results, aiming to improve transplant outcomes and patient well-being.

In the United Arab Emirates, the Chimerism Post-Engraftment Test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 1330 AED, reflecting the sophisticated technology and expertise required to accurately determine chimerism levels. Patients and healthcare providers considering this test can expect a reliable service that contributes significantly to the post-transplant care process.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Chimerism Post-Engraftment Test

Test Name: CHIMERISM POST-ENGRAFTMENT Test

Components: PCR, STR / Fragment analysis

Price: 1330.0 AED

Sample Condition: 4 ml (2 ml min.) whole blood / Bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Indicate Date of Bone Marrow Transplant.

Report Delivery: Sample Daily by 11 am; Report 7 Working days

Test Type: Transplantation pathology

Doctor: Hematologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Indicate Date of Bone Marrow Transplant.

Test Details

Chimerism post-engraftment testing is a medical procedure that is conducted after a bone marrow or stem cell transplant. It is used to determine the level of chimerism in the patient’s blood or bone marrow.

Chimerism refers to the presence of two genetically distinct cell populations in an individual. In the context of transplantation, chimerism occurs when the transplanted cells (donor cells) coexist with the recipient’s own cells (host cells).

The post-engraftment test is usually performed around 30 days after the transplant to assess the success of the transplantation and monitor the patient’s progress. It involves analyzing the patient’s blood or bone marrow samples to determine the percentage of donor cells present.

The test can be conducted using various techniques, including fluorescent in situ hybridization (FISH), polymerase chain reaction (PCR), or flow cytometry. These techniques allow for the detection and quantification of donor cells in the patient’s sample.

The results of the chimerism post-engraftment test provide valuable information about the engraftment of the donor cells and the level of chimerism achieved. High levels of donor cell chimerism indicate a successful transplant, while low levels may suggest graft failure or rejection.

Monitoring chimerism post-engraftment is crucial in determining the effectiveness of the transplantation and guiding further treatment decisions. It helps healthcare professionals assess the risk of graft rejection or relapse of the underlying condition.

In summary, chimerism post-engraftment testing is a medical procedure performed after a bone marrow or stem cell transplant to assess the level of donor cell chimerism in the patient’s blood or bone marrow. It is an important tool in monitoring the success of the transplantation and guiding further treatment.

Test Name CHIMERISM POST-ENGRAFTMENT Test
Components
Price 1330.0 AED
Sample Condition 4 ml (2 ml min.) whole blood \/ Bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Indicate Date of Bone MarrowTransplant.
Report Delivery Sample Daily by 11 am; Report 7Working days
Method PCR, STR / Fragment analysis
Test type Transplantation pathology
Doctor Hematologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Indicate Date of Bone Marrow Transplant.
Test Details

Chimerism post-engraftment testing is a medical procedure that is conducted after a bone marrow or stem cell transplant. It is used to determine the level of chimerism in the patient’s blood or bone marrow.

Chimerism refers to the presence of two genetically distinct cell populations in an individual. In the context of transplantation, chimerism occurs when the transplanted cells (donor cells) coexist with the recipient’s own cells (host cells).

The post-engraftment test is usually performed around 30 days after the transplant to assess the success of the transplantation and monitor the patient’s progress. It involves analyzing the patient’s blood or bone marrow samples to determine the percentage of donor cells present.

The test can be conducted using various techniques, including fluorescent in situ hybridization (FISH), polymerase chain reaction (PCR), or flow cytometry. These techniques allow for the detection and quantification of donor cells in the patient’s sample.

The results of the chimerism post-engraftment test provide valuable information about the engraftment of the donor cells and the level of chimerism achieved. High levels of donor cell chimerism indicate a successful transplant, while low levels may suggest graft failure or rejection.

Monitoring chimerism post-engraftment is crucial in determining the effectiveness of the transplantation and guiding further treatment decisions. It helps healthcare professionals assess the risk of graft rejection or relapse of the underlying condition.

In summary, chimerism post-engraftment testing is a medical procedure performed after a bone marrow or stem cell transplant to assess the level of donor cell chimerism in the patient’s blood or bone marrow. It is an important tool in monitoring the success of the transplantation and guiding further treatment.

SKU: TEST-5473 Category:

Related products